CA48121-3A - 0x0000000000007286
Male & Females of Non-Childbearing Potential
Java
* Stipend may pay up to reflected amount.
Start Date:
October 21, 2026 - 2:15pm
End Date:
November 12, 2026 - 5:30pm
Study Details
Study Number: CA48121
Group Number: 3A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,250.00
Study Criteria
Age: 19 - 55
BMI: 18.5 - 30
Weight Restriction: minimum weight 100 lbs
Study Information
Indication: This investigational medication is being developed to treat narcolepsy.
Route of Administration: Oral
Blood Draws: 19
Study Schedule
Schedule Type: Short stays with returns
Study Length: One 4-Night Stay, One 3-Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 10/5/2026 |
| Thursday | 10/8/2026 |
| Friday | 10/9/2026 |
| Monday | 10/12/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 10/13/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 10/21/2026 2:15:00 PM | Sunday | 10/25/2026 9:45:00 AM | 1 | Lincoln |
| Check-In | Thursday | 11/5/2026 2:00:00 PM | Sunday | 11/8/2026 8:30:00 AM | 2 | Lincoln |
| Return | Thursday | 11/12/2026 6:30:00 AM | Thursday | 11/12/2026 5:30:00 PM | 2 | Lincoln |
